# Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications

- Link: https://www.widthness.com/silencing-the-sars-cov-2-receptor-with-crispr-and-epigenetic-modifications/
- Published: 2020-07-30T09:15:30-05:00
- Author: Curated by Theresa Wysocki

Article by Molly Campbell &#8211; Science Writer. The Hackett Group at EMBL Rome explores epigenetics, genome regulation and cell identity. Recently, the scientists developed a novel CRISPR molecular tool for editing the epigenome, enabling transient modifications that can switch certain genes &#8220;on&#8221; and &#8220;off&#8221; temporarily. The SARS-CoV-2 virus that has caused the COVID-19 global pandemic makes its way into a host cell via a protein known as ACE2, which is involved in a range of physiological functions in the body. What happens when you transiently turn &#8220;off&#8221; the gene that encodes this protein? Can SARS-Cov-2 still enter the cell and cause infection? This is what Hackett and colleagues are currently exploring in animal models, to determine whether epigenetic silencing could be a treatment approach for COVID-19 in humans. [&#8230;] Click here to view original web page at www.technologynetworks.com
